Schrodinger Deal History & Licensing Activity
Schrodinger is a large biotech headquartered in US. Over the past three years, Schrodinger has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (1 deal).
Deals (12mo)
4
Active Trials
4
Top Modality
Small Molecules
Focus Area
Oncology
Schrodinger Pipeline Focus
Therapeutic areas and modalities where Schrodinger is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Schrodinger Strategic Signals
Key indicators of Schrodinger's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
See How Your Asset Matches Schrodinger's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Schrodinger Licensing & Deal Activity
Schrodinger is a large biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Schrodinger ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Schrodinger include Oncology (1 deal and trial). In terms of modality, Schrodinger has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Schrodinger and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Schrodinger's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.